Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;136(3):387-94.
doi: 10.1007/s00432-009-0668-3. Epub 2009 Sep 16.

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators

Affiliations

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators

Yong Wha Moon et al. J Cancer Res Clin Oncol. 2010 Mar.

Abstract

Purpose: Small bowel adenocarcinoma (SBA) is a rare malignancy with a poor outcome. We evaluated the natural history of SBA at a single Korean institute.

Methods: Medical records of 100 patients with SBA were reviewed for clinical characteristics, treatment patterns, outcomes, and prognostic factors.

Results: The most common primary tumor site was the duodenum (82%). Seventy-four patients were diagnosed with stage III/IV disease (28/46 patients, respectively). Sixty-six patients had surgery (R0/R1/R2 in 32/2/32) without operation-related mortality. Of 34 R0/R1-resected patients, 16 received adjuvant chemotherapy. The dominant pattern of recurrence following R0/R1 resection was distant metastasis (29%; 10 of 34 patients). Thirty-four patients with advanced SBA received palliative chemotherapy, showing a response rate of 27.6% and a median progression-free survival of 3.8 months. The median overall survival for all patients and R0/R1-resected patients was 10.5 and 42.1 months, respectively. In multivariate analysis, lower stage, nonduodenal location, and R0/R1 resection were good independent prognostic factors.

Conclusions: Early diagnosis is crucial to improve outcomes of SBA with respect to increasing resectability. Distant metastasis as a dominant pattern of recurrence suggests a potential role for adjuvant chemotherapy. Newer antitumor agents in advanced SBA should be evaluated considering the poor efficacy of current palliative chemotherapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Treatment modalities. CTx chemotherapy, Tx treatment. R0/1/2 indicates R0/1/2 resections. Of 34 R0/1 resected patients, 2 received R1 resection
Fig. 2
Fig. 2
a Overall survival (OS) of all patients, according to the b treatment modalities, c stages, and d years of diagnosis. CI confidence interval, m month, 5Y 5 year
Fig. 3
Fig. 3
a Overall survival according to type of surgery and b palliative chemotherapy. CTx chemotherapy. Candidates of palliative chemotherapy included unresected, R2 resected or recurred patients (n = 87)

References

    1. Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A (2007) Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 14:2263–2269 - PubMed
    1. Aparicio T, Costes L, Moulin V, Locher C, Bidault A, Lecomte T, Mitry E, Taieb J, Landi B, Malka D (2007) Efficacy of recent chemotherapy regimen in advanced small bowel carcinoma. J Clin Oncol 25(18 Suppl): (Abstract 15112)
    1. Barnes G, Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78 - PubMed
    1. Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO (1994) Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1:183–188 - PubMed
    1. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71 - PubMed

Publication types

MeSH terms

LinkOut - more resources